Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 1.00 |
| ▸ | CASP1 | P29466 | 1/20 | 1.00 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.40 |
| ▸ | ESR2 | Q92731 | 2/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.32 |
| ▸ | TRIM24 | O15164 | 1/20 | 0.32 |
| ▸ | TRIM33 | Q9UPN9 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1025357 | 1.00 | TSHR (1.00) | TSHRCASP1CHRNA7ESR2KMT2A | |
| Cyclohexanone Oxime SCHEMBL15106892 | 1.00 | TSHR (1.00) | TSHRCASP1CHRNA7ESR2KMT2A | |
| SCHEMBL3472303 | 1.00 | TSHR (1.00) | TSHRCASP1CHRNA7ESR2KMT2A | |
| SCHEMBL3474721 | 1.00 | TSHR (1.00) | TSHRCASP1CHRNA7ESR2KMT2A | |
| SCHEMBL3190316 | 1.00 | TSHR (1.00) | TSHRCASP1CHRNA7ESR2KMT2A | |
| SCHEMBL1026335 | 1.00 | TSHR (1.00) | TSHRCASP1CHRNA7ESR2KMT2A | |
| Cyclohexanone Oxime SCHEMBL37995 | 1.00 | — | — | |
| Cyclohexanone Oxime SCHEMBL11884936 | 1.00 | TSHR (1.00) | TSHRCASP1CHRNA7ESR2KMT2A | |
| SCHEMBL1025656 | 1.00 | TSHR (1.00) | TSHRCASP1CHRNA7ESR2KMT2A | |
| SCHEMBL1025081 | 1.00 | TSHR (1.00) | TSHRCASP1CHRNA7ESR2KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025088970-A1 | ELECTRODE MIXTURE, ACTIVE MATERIAL MIXTURE, BINDER SOLUTION, PRODUCTION METHOD FOR ELECTRODE MIXTURE, PRODUCTION METHOD FOR ELECTRODE, ELECTRODE, AND SECONDARY BATTERY | 株式会社クレハ | 2025-05-01 | — | — | WO | disclosed |
| US-11963527-B2 | Compounds, compositions, and methods for altering insect and organism behavior | BASF CORPORATION (US) | 2024-04-23 | — | — | US | disclosed |
| US-20230335741-A1 | BINDER, ELECTRODE MIXTURE, ELECTRODE, AND NON-AQUEOUS ELECTROLYTE SECONDARY BATTERY | KUREHA CORPORATION (JP) | 2023-10-19 | — | — | US | disclosed |
| EP-4206273-A1 | BINDER, ELECTRODE MIXTURE, ELECTRODE, AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY | Kureha Corporation (JP) | 2023-07-05 | — | — | EP | disclosed |
| WO-2023054702-A1 | ALDEHYDE COMPOUND PRODUCTION METHOD AND DIHYDROISOXAZOLE COMPOUND PRODUCTION METHOD | クミアイ化学工業株式会社 | 2023-04-06 | — | — | WO | disclosed |
| WO-2022110930-A1 | METHOD FOR AMMOXIMATION OF MACROCYCLOALKANONE | 中国天辰工程有限公司 | 2022-06-02 | — | — | WO | disclosed |
| EP-2241552-B1 | PRODUCTION METHOD AND BECKMANN REARRANGEMENT CATALYST FOR PRODUCING A CYCLIC LACTAM COMPOUND | UNIV NAGOYA NAT UNIV CORP (JP) | 2018-11-14 | — | — | EP | disclosed |
| US-9411226-B2 | Chemically amplified resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-08-09 | — | — | US | disclosed |
| US-9411226-B2 | Chemically amplified resist composition and patterning process | SHIN-ETSU CHEMICAL CO., LTD. (JP) | 2016-08-09 | — | — | US | disclosed |
| EP-2241552-A1 | PRODUCTION METHOD AND BECKMANN REARRANGEMENT CATALYST FOR PRODUCING A CYCLIC LACTAM COMPOUND | National University Corporation Nagoya University (JP) | 2010-10-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11963527-B2 | Compounds, compositions, and methods for altering insect and organism behavior | ACHE, DDT, MGLL | TSHR 2908/4885CASP1 1427/4885CHRNA7 3301/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.